{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-001771","form_type":"8-K","ticker":"MTNB","cik":"0001582554","company_name":"Matinas BioPharma Holdings, Inc.","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.698484+00:00","generated_at":"2026-06-07T01:29:29.328015+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Matinas BioPharma updates corporate presentation; no specific disclosures","bullets":["Filed an updated corporate presentation dated January 9, 2024, for use at conferences and investor meetings.","No financial results, pipeline updates, or material agreements were disclosed in the filing.","The presentation is attached as Exhibit 99.1 but its content is not summarized in the 8-K.","Ticker: MTNB (NYSE American). Event is a routine Regulation FD disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-001771","json":"https://secwatch.observer/filing/0001493152-24-001771.json","markdown":"https://secwatch.observer/filing/0001493152-24-001771.md","text":"https://secwatch.observer/filing/0001493152-24-001771.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582554/000149315224001771/0001493152-24-001771-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582554/000149315224001771/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:29:29.328015+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}